By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akorn, Inc. 

1925 West Field Court

Lake Forest  Illinois  60045  U.S.A.
Phone: 847-279-6100 Fax: 847-236-3823



Drug Discovery

Company News
Akorn, Inc. (AKN) Receives FDA Approval For Phenylephrine HCl Ophthalmic Solution 1/20/2015 7:44:49 AM
Akorn, Inc. (AKN) Confirms Generic Durezol® Patent Challenge 1/16/2015 7:22:59 AM
Shenzhen Hybio Pharma Sells US Rights For Generic MS Drug To Akorn, Inc. (AKN) 1/8/2015 12:00:18 PM
Akorn, Inc. (AKN) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 12/19/2014 7:51:43 AM
Akorn, Inc. (AKN) Reports Preliminary 2014 Third Quarter Results 11/6/2014 10:57:47 AM
Akorn, Inc. (AKN) Announces Third Quarter 2014 Earnings Release And Conference Call Information 10/21/2014 10:43:37 AM
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014 5:53:07 AM
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal 9/12/2014 6:38:34 AM
Akorn, Inc. (AKN) Completes Acquisition Of VersaPharm 8/12/2014 7:51:00 AM
Akorn, Inc. (AKN) Reports Preliminary 2014 Second Quarter Results 8/5/2014 7:53:24 AM